Company Profile

Remedium Bio Inc
Profile last edited on: 10/1/2023      CAGE: 932B7      UEI: LHVFPCAFGKD8

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2020
First Award
2023
Latest Award
2023
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1116 Great Plain Avenue Suite 203
Needham, MA 02492
   (409) 354-8176
   N/A
   www.remedium-bio.com
Location: Single
Congr. District: 04
County: Norfolk

Public Profile

Remedium Bio is a Boston area gene therapy company focused on the development of curative treatments for a number of highly debilitating conditions. Our fundamental approach to product development utilizes proven technologies in novel ways to treat well-characterized disease pathology. To streamline R&D, we modularly apply elements of proventechnology to develop local, targeted treatments focusing on clinically validated molecules and mechanistic pathways. Today, our leading candidates include gene therapy treatments in the fields of Rheumatology / Osteoarthritis, Endocrinology / Diabetes, and Neurology / Stroke.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 1 NSF $274,966
Project Title: Development of an Adjustable Gene Therapy Platform Technology

Key People / Management

  Alexey Seregin

Company News

There are no news available.